R&D Systems™ Recombinant Viral B8R Biotinylated Protein

Description

Extensive quality control produces industry leading bioactivity and lot-to-lot consistency that instills confidence in results and ensures reproducibility.

The Recombinant Viral B8R Biotinylated Protein is derived from CHO. The Recombinant Viral B8R Biotinylated Protein has been validated for the following applications: Bioactivity.

Specifications

• Accession Number: P24770
• For Use With (Application): Bioactivity
• Gene ID (Entrez): 3707661
• Molecular Weight (g/mol): Theoretical M.W.: 30kDa (unlabeled)
• Quantity: 25μg
• Source: Chinese Hamster Ovary cell line,CHO-derived viral B8R protein Lys18-Ser272,with a C-terminal 6-His tag
• Storage Requirements: Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70° C as supplied. 1 month, 2 to 8° C under sterile conditions after reconstitution. 3 months, -20 to -70° C under sterile conditions after reconstitution.
• Endotoxin Concentration: <0.10 EU per 1μg of the protein by the LAL method.
• Common Name: B8R
• Gene Symbol: B8R
• Biological Activity: Measured by its ability to inhibit rhIFN-gamma mediated protection of HeLa human cervical epithelial carcinoma cells to viral lysis. Meager, A. (1987) in Lymphokines and Interferons, a Practical Approach. Clemens, M.J. et al. (eds): IRL Press. 129. Th ED50 for this effect is typically 0.5-3ng/mL.
• Conjugate: Biotin
• Species: Virus
• Recombinant: Recombinant
• Expression System: Chinese Hamster Ovary cell line, CHO-derived Lys18-Ser272, with a C-terminal 6-His tag
• Purity or Quality Grade: >95%, by SDS-PAGE visualized with Silver Staining and quantitative densitometry by Coomassie™ Blue Staining